Lung
Emphysema
Loss of the walls of the distal airspaces (respiratory bronchioles, alveolar ducts and alveoli), leaving fewer, dilated airspaces. The lungs lose surface for gas exchange and elastic recoil, trap air and overinflate. It often overlaps with chronic bronchitis as chronic obstructive pulmonary disease (COPD).
Causes and risk factors
- Cigarette smoking (centriacinar emphysema)
- α1-antitrypsin deficiency (panacinar emphysema)
Gross pathology
- Centriacinar (centrilobular) emphysema: holes in the centre of the lobules, worst in the upper lobes, often with black anthracotic pigment; the smoker’s pattern.
- Panacinar emphysema: the whole acinus is lost, worst at the bases; typical of α1-antitrypsin deficiency.
- Paraseptal (distal acinar) emphysema: localised subpleural bullae, which can rupture and cause pneumothorax; not related to smoking.
- The lungs are overinflated and the diaphragm flattened; large bullae form where much lung has been lost.
Under the microscope
- Loss of distal airspace walls: bronchioles, alveolar ducts and alveoli.
- The remaining airspaces are dilated, leaving far less wall, and far fewer capillaries, for gas exchange.
How it develops
- In smokers, the respiratory bronchioles in the proximal part of the acinus are lost first; distal alveoli are spared at first (centriacinar emphysema).
- The walls of the distal airspaces are destroyed and the remaining airspaces dilate, leaving less surface for gas exchange.
- Elastic recoil is lost and compliance rises; residual volume and total lung capacity increase.
- The diaphragm flattens and works less efficiently, so breathing takes more work; accessory muscles are recruited, and pursed-lip breathing keeps distal airways from collapsing.
- With air trapping and reduced ventilation, PaO2 falls, PaCO2 rises and respiratory acidosis follows; loss of the vascular bed raises pulmonary arterial pressure.
Complications
- Respiratory failure with respiratory acidosis
- Pulmonary hypertension
- Pneumothorax from a ruptured bulla
- The loss of lung tissue is permanent, even after stopping smoking
Investigations
- Spirometry and lung volumes
- A reduced FEV1/FVC ratio that does not fully reverse, a raised total lung capacity and residual volume (air trapping).
- Gas transfer (DLCO)
- Reduced, because the alveolar walls and their capillaries are destroyed.
- Chest radiograph and CT
- Hyperinflated lungs with flattened diaphragms; CT shows destroyed airspaces and bullae.
- Alpha-1 antitrypsin level
- Low in panacinar emphysema, especially in young people or non-smokers.
Drug treatment
- β2-Adrenergic agonists: Bronchodilators: short-acting drugs relieve symptoms within minutes; long-acting ones are added to inhaled corticosteroids for control.
- Inhaled muscarinic antagonists (LAMA, SAMA): Inhaled bronchodilators that block acetylcholine at muscarinic receptors in the airways; with long-acting β2 agonists, the foundation of COPD treatment.
- Inhaled corticosteroids (ICS): The drugs of choice for long-term control of persistent asthma: they treat the airway inflammation itself, and work only if taken regularly.
Drugs to avoid or use with care
- β-Adrenergic blockers (β-blockers) (Use with care): They can worsen airflow obstruction; a cardioselective drug is preferred when one is needed.
- Opioid analgesics (Use with care): They depress the breathing drive in patients who already retain carbon dioxide.
- Antitumour antibiotics (anthracyclines and bleomycin) (Use with care): Bleomycin causes pneumonitis and fibrosis; risk rises with poor lung function and high-concentration oxygen.
Anatomy involved
Connected topics
Written from
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 5, The Lung, pp. 113–115, figs 5-17 to 5-23
Educational reference. Not medical advice, diagnosis or treatment.